Remove Competition Remove Government Remove Prescription Remove Prospecting
article thumbnail

How to Market to Doctors, Physicians, and Other Health Care Professionals

Healthcare Success

Not only are doctors and decision-makers difficult to reach—and even more difficult to persuade—you have to contend with a ton of competition. Here are two ways to define your doctor audience: Target your best prospects Enhance your database to target more precisely. Target Your Best Prospects. More data is always better.

Doctors 61
article thumbnail

US government plans proposal to push down Medicaid drug prices

Pharmaceutical Technology

The US Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) have announced steps to push down prescription drug prices under Medicaid as part of a new proposal. The CMS will not use this process to limit access to any of the surveyed medicines, based on the fact sheet.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA AdCom votes unanimously in favour of OTC oral contraceptive

Pharmaceutical Technology

The FDA approved Opill for prescription use in 1973. But this was followed by a lower court decision that limited access to Mifeprex, which was later overturned by the US Supreme Court ruling upheld the FDA’s rules governing the sale of the drug. The therapy only contains the hormone progestin and is taken once daily.

FDA 52
article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents. Novartis vs Greece.

article thumbnail

OTC Narcan will cost ‘less than $50’, company says

Pharmaceutical Technology

Public interest groups including government agencies, harm reduction groups, and emergency responders pay less than $50 out of pocket for one carton of the spray, according to Emergent. On March 29, 2023, the US Food and Drug Administration (FDA) granted approval that made Narcan the opioid treatment drug to be sold without a prescription.

article thumbnail

Q&A: As RSV vaccine approvals loom, regulators need to devise vaccination strategies

Pharmaceutical Technology

GSK’s leading competitor, Pfizer also has a pending Prescription Drug User Fee Act ( PDUFA ) date for its RSV vaccine, PF-06928316 or RSVpreF, which is aimed at individuals ages 60 years and above, for May 31. This interview has been edited for length and clarity.

article thumbnail

Legal challenges put off label use of gender affirming care drugs in jeopardy

Pharmaceutical Technology

The laws proposed in several bills range in their potential influence; from restricting the prescription of gender-affirming drugs to criminalising the use of such drugs to allowing states to pursue lawsuits against parents who allow children to access such treatments. But the funding is not there, he adds.

Ethics 144